OS

Oliver Schoor

IG Immatics Biotechnologies Gmbh: 528 patents #3 of 99Top 4%
IG Inmatics Biotechnologies Gmbh: 6 patents #1 of 8Top 15%
📍 Rötteln, DE: #3 of 115 inventorsTop 3%
Overall (All Time): #325 of 4,157,543Top 1%
539
Patents All Time

Issued Patents All Time

Showing 251–275 of 539 patents

Patent #TitleCo-InventorsDate
10925948 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh, Claudia WAGNER +2 more 2021-02-23
10919931 Immunotherapy against several tumors including neuronal and brain tumors Toni Weinschenk, Claudia Trautwein, Norbert Hilf, Steffen Walter, Harpreet Singh 2021-02-16
10906936 Immunotherapy against several tumors including neuronal and brain tumors Toni Weinschenk, Claudia Trautwein, Norbert Hilf, Steffen Walter, Harpreet Singh 2021-02-02
10905720 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-02-02
10905719 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-02-02
10898558 Method of treating with a peptide Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh 2021-01-26
10899814 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Heiko SCHUSTER, Annika Sonntag, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +2 more 2021-01-26
10899813 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Heiko SCHUSTER, Annika Sonntag, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +2 more 2021-01-26
10899811 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +1 more 2021-01-26
10899810 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Heiko SCHUSTER, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +1 more 2021-01-26
10899809 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Colette Song, Jens Fritsche, Toni Weinschenk, Harpreet Singh 2021-01-26
10899808 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Colette Song, Jens Fritsche, Toni Weinschenk, Harpreet Singh 2021-01-26
10899807 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Colette Song, Jens Fritsche, Toni Weinschenk, Harpreet Singh 2021-01-26
10899806 Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Andrea Mahr, Toni Weinschenk, Valentina Goldfinger, Jens Fritsche, Harpreet Singh 2021-01-26
10898561 Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Toni Weinschenk, Jens Fritsche, Harpreet Singh, Andrea Mahr, Martina Ott +1 more 2021-01-26
10898560 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh, Claudia WAGNER +2 more 2021-01-26
10898559 Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh, Claudia WAGNER +2 more 2021-01-26
10899812 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Heiko SCHUSTER, Annika Sonntag, Daniel Johannes KOWALEWSKI, Jens Fritsche, Toni Weinschenk +2 more 2021-01-26
10898518 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-26
10898519 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-26
10898557 Method of treating with a peptide Andrea Mahr, Toni Weinschenk, Jens Fritsche, Harpreet Singh 2021-01-26
10894064 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-19
10888582 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-12
10888583 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-12
10888584 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-12